Kadimastem

Kadimastem

A clinical stage biotech company using A cutting-edge TECHNOLOGY PLATFORM for the Development, Manufacturing, & Bio-Banking of human functional cells. Learn more

Launch date
Employees
Market cap
€6.7m
Enterprise valuation
€8m (Public information from Sep 2024)
Company register number 514192558
Sapir South District (HQ)
Authorizing premium user...